Sartorius Stedim Biotech's total assets for Q4 2022 were €5.07B, a decrease of -0.62% from the previous quarter. GB:0RG8 total liabilities were €― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.